Imaging the dopaminergic system in suspected parkinsonism, drug induced movement disorders, and Lewy body dementia
- PMID: 15657499
- DOI: 10.1097/00006231-200502000-00002
Imaging the dopaminergic system in suspected parkinsonism, drug induced movement disorders, and Lewy body dementia
Abstract
This review discusses the role of pre- and post-synaptic dopaminergic imaging in suspected Parkinson's disease, vascular parkinsonism, the parkinsonian syndromes, drug induced movement disorder, and Lewy body dementia. It is envisaged that this information may be useful to neurologists, psychiatrists, physicians/geriatricians, radiologists and nuclear medicine physicians.
Similar articles
-
Imaging in dementia with Lewy bodies: a review.Nucl Med Commun. 2007 Jul;28(7):511-9. doi: 10.1097/MNM.0b013e3281e20a12. Nucl Med Commun. 2007. PMID: 17538391 Review.
-
Role of dopamine transporter imaging in routine clinical practice.Mov Disord. 2003 Dec;18(12):1415-23. doi: 10.1002/mds.10592. Mov Disord. 2003. PMID: 14673877 Review.
-
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.Brain. 2011 Nov;134(Pt 11):3146-66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2. Brain. 2011. PMID: 21810889 Review.
-
Validation in SPECT imaging on presynaptic dopaminergic deficit for dementia with Lewy bodies and degenerative Parkinsonism.J Neurol Sci. 2018 Sep 15;392:116. doi: 10.1016/j.jns.2018.07.017. Epub 2018 Jul 21. J Neurol Sci. 2018. PMID: 30055381 No abstract available.
-
Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.Int J Neuropsychopharmacol. 2007 Apr;10(2):231-44. doi: 10.1017/S146114570600647X. Epub 2006 Feb 1. Int J Neuropsychopharmacol. 2007. PMID: 16448581
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical